And in a high-risk population such as outpatients with T2D, our group recently reported, that MR-proANP with a cut-off of less than 60 pmol/l was efficient to rule out HFrEF and at this cut-off, the highest ability to similarly rule out HFpEF was obtained. Here, NPPA is linked to type 2 diabetes mellitus.